TOFACITINIB

Product NDC
42571-377
Requested package NDC
42571-377-05
11-digit product format
425710377
Labeler code
42571
Product ID
42571-377_57e3cc57-9fe8-b19b-e063-6394a90aae90
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
tofacitinib
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Micro Labs Limited
Application
ANDA209738
Marketing category
ANDA
Marketing start
2026-06-08
Substance
TOFACITINIB CITRATE
Active strength
10 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A209738-001TOFACITINIB CITRATETOFACITINIB CITRATEEQ 5MG BASETABLET / ORALAB2023-03-13
A209738-002TOFACITINIB CITRATETOFACITINIB CITRATEEQ 10MG BASETABLET / ORALAB2026-06-03

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A209738-001AB
A209738-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-13011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-1331067a03dcf5…
2025-08-23 18:47 UTC2025-08A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-136a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-13fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-13b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-1303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-132680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-135bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-13d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-13d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-1379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-13301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-131e350fbaab3a…
2024-05-31 18:47 UTC2024-05A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-138072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-136a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-131c564ffb4f44…
2023-12-20 04:57 UTC2023-12A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-13ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-13a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-139b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-13a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-133f0d92c62455…
2023-05-13 08:27 UTC2023-05A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORAL2023-03-13053a50430f4f…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A209738-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORALAB2023-03-13a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A209738-002TOFACITINIB CITRATEEQ 10MG BASETABLET / ORALAB2026-06-03a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A209738-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A209738-002AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
TOFACITINIB
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TOFACITINIB CITRATE10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
O1FF4DIV0DInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1357541Internal RxNorm lookup
2048566Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
ffa6819b-23a4-478b-8fb7-cc90e8142fc5Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TOFACITINIBTOFACITINIBMicro Labs Limitedffa6819b-23a4-478b-8fb7-cc90e8142fc52026-06-04Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209738
application number: ANDA209738
ndc (package): 42571-377-05
ndc (product): 42571-377
ndc11 (package): 42571037705

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleStatus
42571-377-0542571037705500 TABLET, FILM COATED in 1 BOTTLE (42571-377-05)2026-06-080Current